The European Medicines Agency (EMA) has accepted AstraZeneca Plc's (NASDAQ:AZN) marketing authorization application for sipavibart for pre-exposure prophylaxis (prevention ...
Benzinga via Yahoo
2 hours ago
Zacks via Yahoo
AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer
5 days ago
AstraZeneca's Blockbuster Cancer Drug Imfinzi Flunks As Follow-Up In Type Of Early-Stage Lung Cancer, But Hits Primary...
6 days ago
China Approves AstraZeneca's Tagrisso-Chemotherapy Combo Regime For Previously Untreated Lung Cancer Patients
FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen
View all
British-Swedish pharmaceutical company
astrazeneca.com
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. Wikipedia
Stock price: AZN (NasdaqGS) $77.71 -0.28 (-0.36%)
Mon, Jul 1, 2024, 2:40PM EDT